HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adriamycin cardiomyopathy: pathophysiology and prevention.

Abstract
Current knowledge about adriamycin cardiomyopathy indicates that the major cause of this condition is increased oxidative stress although the drug's antitumor action in patients may involve other mechanisms. Controversies about the different antioxidants in preventing cardiomyopathy likely stem from the fact that antioxidants must be effective in both the lipid and water phases, and the dose must be optimal, in order to be protective. Probucol, an antioxidant and promoter of endogenous antioxidants, is one such agent. Conducting clinical trials with an optimal dose of probucol is the next step and should make this great anticancer drug safer and more efficient in the fight against the cancer.
AuthorsP K Singal, N Iliskovic, T Li, D Kumar
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 11 Issue 12 Pg. 931-6 (Oct 1997) ISSN: 0892-6638 [Print] United States
PMID9337145 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antibiotics, Antineoplastic
  • Antioxidants
  • Doxorubicin
  • Probucol
Topics
  • Animals
  • Antibiotics, Antineoplastic (adverse effects)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Antioxidants
  • Cardiomyopathies (chemically induced, physiopathology, prevention & control)
  • Clinical Trials as Topic
  • Doxorubicin (administration & dosage, adverse effects, toxicity)
  • Humans
  • Neoplasms (drug therapy)
  • Oxidative Stress
  • Probucol (therapeutic use)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: